SCHEMBL6174287

SCHEMBL6174287

CC(c1ccnc2cc(Cl)ccc12)C1NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 13/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
NR4A2 P43354 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173610 0.91 IGF1R (0.37) IGF1RSMN1; SMN2LMNA
SCHEMBL6175589 0.89 IGF1R (0.38) IGF1RSMN1; SMN2LMNA
SCHEMBL6174916 0.87 IGF1R (0.35) IGF1RSMN1; SMN2
SCHEMBL6174393 0.85 SMN1; SMN2 (0.43) IGF1RSMN1; SMN2LMNA
SCHEMBL6174902 0.83 SMN1; SMN2 (0.39) IGF1RSMN1; SMN2LMNA
SCHEMBL6172293 0.83 IGF1R (0.40) IGF1RSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL6174980 0.83 IGF1R (0.36) IGF1RNR4A2LMNA
SCHEMBL6174021 0.83 IGF1R (0.36) IGF1RSMN1; SMN2LMNA
SCHEMBL6176324 0.80 IGF1R (0.35) IGF1RSMN1; SMN2LMNA
SCHEMBL6171605 0.80 LMNA (0.39) IGF1RSMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed